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Abstract 
To me science, as a concept, has always been the never-ending search for the "why" and 
"how" different elements around us do what they do. This concept appeals to highly detailed and 
inquisitive people that are not content to leave things as they are but want to search further for 
explanations. In a medical clinic these questions have paramount importance as their answers can 
have serious impact on the health and life of a patient seeking care. Medical practitioners need to 
understand what they are dealing with down to the microscopic level to give the best and most 
appropriate care possible to each patient. This, however, is a daunting task, especially with new 
research leading to new discoveries every day. Early in the new century a sample of microbes 
from the genus Peptostreptococcus was discovered to be two different species from the genus 
rather than the singular species the sample was originally believed to be. Consistent 
differentiation proved to be difficult between the two species as they were hard to culture, or 
grow in a lab, even though they are implicated in certain diseases. Our goal for this research was 
to design primers that could be used to easily identify, on a genetic level, an unknown microbe of 
Peptostreptococcus to allow for more precise treatment of a disease or infection. These primers 
would consist of complimentary genetic code for target gene sequences in the bacteria combined 
with SYBR green for fluorescence. If the primers anneal to the target sequences appropriately 
during polymerase chain reaction (PCR), then the fluorescence would be the indicator of the 
target gene's presence. 
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Process Analysis Statement 
This project definitely had humble beginnings. The idea for our research first came to be 
as an extension of a project assigned in Dr. McKillip's Microbiology (BIO 313) class that 
Spencer and I shared. The project dealt with the identification of a specific microbe from a real-
world sample through the use of several determinative tests we had been discussing in lecture 
and lab. In Spencer's project, specifically, he had difficulty differentiating between two specific 
bacteria of the Peptostreptococcus genus. He approached me in March 20 17 with the idea of 
creating an outside research project to find a new and effective way of differentiating between 
those two bacteria, P. anaerobius and P. stomatis. It was not until we approached Dr. McKillip 
about pursuing the research that he suggested that such a topic would be appropriate for a senior 
Honor's thesis. 
Preliminary research on P. anaerobius and P. stomatis was slow to say the least. The two 
bacteria had only been distinguished as two separate species in the late 2000's so there was not 
much prior data on tests that would defmitively differentiate the two. Since our project was first 
viewed as an extension of the classroom Microbiology project, we tried to model our research 
process based on the differentiating tests we had learned about among others we researched. 
Thus, our first proposed method of research was to use cultures of the two bacteria and 
expose the two to iron shavings. We knew from our research that P. anaerobius produces 
isovaleric acid as an end product of metabolism while P. stomatis does not. Our thought process 
was that, since isovaleric acid is corrosive to metals, it will oxidize the iron shavings and, if there 
was observed degradation of the iron shavings placed into the culture, then that would be 
indicative of P. anaerobius. This, we believed, would be a cost-effective way for medical clinics 
to differentiate between the two bacteria as iron shavings would not be expensive to procure. 
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This is where the research project became real and exciting for the pair of us and could be 
considered our first major "breakthrough" in our project. For the first time we were moving away 
from the preliminary research stage, which had spanned several months, and moved into 
devising our own ways to solve the problem. It had been a long time coming, but we had devised 
what could have been our own small contribution to science and, even though this first method 
did not end up becoming the procedure we used for our project, it was still an important step in 
our path that would eventually take us to our results. 
Eventually, however, we had to move on from our first method and think of a new way to 
differentiate the two bacteria. This came to be, ultimately, because we could not think of a way 
to quantify the amount of degradation in the iron shavings as a result of isovaleric acid 
production. P. anaerobius does not produce a large amount of isovaleric acid during its 
metabolism so, even if some iron is broken down in the culture, it would be difficult to measure, 
or even observe with the eye, any degradation. As a result, we decided to pursue differentiation 
based on the genetic material of the two bacteria. 
In our research we learned that P. anaerobius had a higher content of genetic material 
than P. stoma tis, so we figured that there would be some genes present in P. anaerobius alone. 
The new plan was to find three genes unique toP. anaerobius and design primers to match that 
material and indicate through PCR whether the specific sequences were present in a sample and, 
thus, distinguishing between the two bacteria. In the clinical setting, since the primers would 
already be designed from our research, it would be simple and cost-effective to obtain these 
primers and use them to identify the microbe sample in question. This ultimately turned out to be 
a better process than our first idea and became the method our research was based on. 
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Choosing proper DNA sequences unique toP. anaerobius took several hours searching 
through online libraries of gene sequences known to appear in the two bacteria. Our selections 
then had to be further narrowed down depending on their appropriateness and ability to design 
primers based on the sequence. Once the three sequences ifolP, galT, and galK) were decided 
upon it was finally time to order the materials which included samples of the bacteria, 
components for our PCR "recipe," and media to house the samples. The functions of the three 
target genes include, forfolP, the production ofthe protein dihydropteroate synthetase, an 
enzyme that catalyzes the formation of a precursor of folate derivatives called 6-
hydroxymethyl-7 ,8-dihydroprotien. Next, galT codes for a protein involved in galactose 
metabolism as a subset of carbohydrate metabolism. Finally, ga/K codes for a protein that 
catalyzes the transfer of a phosphate group from ATP to D-galactose also as a part of galactose 
metabolism. Finding bacterial samples of P. anaerobius and P. stomatis proved to be challenging 
to find as well. In fact, the sample of P. stomatis was obtained from Europe. Much of the recipe 
was designed from Dr. McKillip's suggestion and experience with past projects regarding PCR. 
At this point we were ready to begin the meat of our research. The timeframe of our 
research coincided with the beginning of the spring semester 2018, a semester in which Spencer 
would spend studying abroad in Argentina. While we remained in contact throughout the 
semester, most of the research fell to me during the semester. We had decided to test each of the 
three primer sequences in triplicate, meaning that PCR was run on each primer in a series of 
three trials. Prior to the first trial being run, and whenever it was necessary, DNA samples had to 
be extracted from our sample bacteria and measured for quality. It is usually a good idea to 
perform the process several times to prove the reproducibility of your results throughout the 
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experiment. It just gives your data another level of appropriateness when your methods are 
scrutinized. 
Research had its immediate challenges. This is not altogether surprising as many times 
the components of PCR need to be adjusted to give good and reproduceable results. A large issue 
at the beginning of the research-gathering process was that the melting temperatures were not as 
clear as they could be, and the graphs ended up being a bit jumbled. This led into the first of 
several trials that had to be re-done. At the suggestion of Dr. McKillip we tried a few steps to 
optimize the PCR recipe, specifically upping the amount of magnesium chloride we used in the 
solution in order to enhance the DNA polymerase activity and increase the robustness of the 
overall reaction. This led to improved results, but this change would not be the last we made 
throughout the research process. 
One strange result that began cropping up in March that needed to be rectified was that 
the "Negative" tube was showing some fluorescence in our results. This was not supposed to be 
the case because the Negative tube should have no DNA sample for our SYBR green to attach to 
and fluoresce. Somehow, during my micro pipetting of these trials, some sample of P. 
anaerobius, P. stomatis, or really anything was contaminating this tube so I needed to adjust my 
procedure. It was a simple fix, really, that focused more on being patient and taking more time 
with each triaL For each subsequent trial, I readied the Negative tube first before any of my 
experimental tubes or the positive control tube. This, and the sterile environment under the hood 
I was working in, would guarantee that no contaminate could wind up in the Negative tube. 
Another problem arose with the quality of the DNA samples we collected from our 
bacteria samples. They were of decent quality but an improvement in this aspect could lead to 
improved results in our trials. The fix to this problem was a fairly simple one, just an addendum 
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to the DNA extraction process I had followed before. The idea was to pass the sample through a 
specialized tube toward the end of the extraction that is specially designed to attract DNA 
material. This helps prevent any loss of material in the process of extraction, so we have more to 
work with when we are running our trials. It was after this adjustment that we started seeing 
much improved results in our trials as compared to our results we had toward the beginning of 
gathering research. 
Overall, I was really happy with our research process. The different adjustments made to 
the DNA extraction and the PCR recipe led to better results, which is always a relief to see. I 
appreciated the flexibility of our process and our timeframe which allowed us to repeat trials as 
needed to obtain better data. The need, however, to perform several trials over again was 
consistently nerve-racking. What people not familiar with the PCR process might be interested to 
learn is how methodical the procedure really is. 
To put it in perspective, to make everything in the "recipe" one needs to be micro 
pi petting, many times only a single microliter of "ingredient," into several small centrifuge tubes. 
So, there are many things that go into the recipe and constitute such a small amount of what will 
go into the tube, many times what seems to only be a drop of liquid - and there are upwards of 4-
8 tubes that need to be made for the trial. All at the same time, the researcher needs to be vigilant 
and careful of what he or she is adding to each tube, what he or she has already added to the 
tube, and what he or she needs to add to the tube in the future. With varying amounts of 
materials and different materials altogether going into different tubes this can become a lot of 
information to keep track of at the same time and one mistake will ruin your results. I honestly 
can't remember how many times I had to scrap a tube because my thoughts wandered for a 
Stewart 6 
moment or someone came into the lab to speak to me. It was always better to start over because 
if one tube had been incorrect during the trial, then I would be redoing the entire trial later. 
The above also does not even go into the range of emotions one feels when they actually 
perform the reaction. Firstly, you feel a sense of relief because you have everything you need 
ready, you have pipetted everything properly, and you are hopeful of good results. Now you 
might be hopeful, but even if you think your methods are appropriate and you have carried them 
out well there is still that fear and nervousness of your results not turning out the way you 
expect. It took just over three hours for my reaction to run its course in each trial so I had that 
time to sit on my hands and worry, which was never a very nice time for me. There is a bit of a 
tradeoff later, though, when you come back to the computer and see that you have done 
everything correctly and you are getting good data, which is definitely a huge relief. 
At the beginning of this project I would have never expected it to take so long and here 
now, at the end of it all, I feel only appreciation for the people who helped get me to this point. 
The senior Honor's thesis was something I had worried about ever since I had entered the college 
and I was extremely fortunate for such an excellent opportunity to fall into my lap. Dr. McKillip 
has been amazing throughout this process as he was always helpful and willing to supply 
suggestions to improve our results during the experimental phase. Spencer has been fantastic as 
well. He is a dependable person by nature and was always committed to what was, to him, an 
outside research project going on while he studied abroad. I feel nothing but appreciation for the 
pair of them and happiness for the opportunity to work with them and construct this project. 
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Unknown Bacteria: Differentiating between Peptostreptococcus anaerobius and Peptostreptococcus 
stomatis for the Clinic 
Goodman, MarkS. and Stewart, Michael B. 
Abstract 
The cornerstone of this research was to differentiate between the closely-related species of 
Peptostreptococcus anaerobius and Peptostreptococcus stomatis from a nucleotide sequence 
perspective. This topic was decided because they have similar chemical properties that do not readily 
distinguish them (Holt, Sneath & Krieg, 1994) and they are difficult to culture in a timely manner 
(Murdoch, 1998). In the past, the solution to cases involving the genus Peptostreptococcus was to simply 
treat with one uniform amount of penicillin since the drug resolved cases involving both of these species 
of Peptostreptococcus (Minces et al., 2010). The problem with this action is the minimum inhibitory 
concentration (MIC) of antibiotic needed to kill P. anaerobius and P. stomatis differs for not just 
penicillin, but also a host of other drugs including metronidazole, clindamycin, and cefoxitin (Ki:ini:inen et 
al., 2007). Due to these differences, the methods used in this experiment to differentiate P. anaerobius 
and P. stomatis included using the PCR technique to elongate three specific gene sequences found in P. 
anaerobius that are not found in P. stomatis. These gene sequences include gaiT, foiP, and gaiK. The use 
of commercial PCR techniques such as the one performed will continue to increase, making the 
performed methods a valuable asset to the differentiation between these two species. Results of this 
PCR screening revealed that the melting temperatures for the designed primer sequences were not 
significantly different between the two species. These results indicate that the three chosen gene 
sequences are not appropriate for differentiation by melting temperature and, thus, new sequences 
need to be chosen and tested to further this line of research between these two species. 
Introduction 
Differentiation between Peptostreptococcus anaerobius and Peptostreptococcus stomatis is of 
great importance in the clinical realm. Specifically, there have been various links between 
gastrointestinal procedures and the occurrence of Peptostreptococcus induced endocarditis (Pathak et. 
al, 2013; Minces et al., 2010) . There are more and diverse outcomes of these two species causing 
infection, explicated in more detail in the lit~rature portion. The minimum inhibitory concentration for 
50% inhibition of the species in question (MICSO) for P. anaerobius is significantly higher than the MICSO 
for P. stomatis (Ki:ini:inen et al, 2007). Distinguishing between these bacteria means patients potentially 
may be able to take in reduced amount ofthe antibiotic, thereby reducing the likelihood of adverse 
effects due to exposing the body to fewer exogenous products (Eiding, 2012). A more defined need for 
the product leads to a more efficient clinic where antibiotics are not used in excess amounts. Based on 
background literature, such as Bergey's Clinical Bacteriology, the two species of Peptostreptococcus are 
not very well differentiated. The goal of this research was to differentiate between P. anaerobius and P. 
stomatis in order to establish information in the literature as a means tci differentiate them. It was 
predicted that using these designed primer sequences to measure their melting temperatures would 
reveal that P. anaerobius would have an annealing temperature for the primer sequences due to its 
inclusion of the gaiT, foiP, and gaiK genes, whereas there should not be an analogous annealing 
temperature for P. stomatis at these points. Furthermore, the intention of this research was to be used 
as a confirmatory test between whether the implicated bacteria is either. of the species stomatis or 
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anaerobius. Future research may include discrete application in the realm of genitourinary-generated 
Peptostreptococcus spp. endocarditis. 
Literature 
The presence of the species Peptostreptococcus stomatis and anaerobius proliferates in many 
clinically-relevant areas in patients reporting to a medical clinic. Specifically, P. stomatis is implicated in 
the following pathologies: oral cavity infections, dentoalveolar abscesses and endodontic infections 
(Elizabeth Carmel Murphy & lnga-Maria Frick, 2012). Peptostreptococcus anaerobius is instead found in 
abdominal cavity infections, female urogenital tract infections and rarely infective endocarditis 
(Elizabeth Carmel Murphy & lnga-Maria Frick, 2012). In the case of infective endocarditis, it is known to 
infect prosthetic valves (Pathal et al., 2013)}. This has implications in the necessity of further procedures 
to correct any prosthetic valve damage. As a further statement ofthe complexity of Peptostreptococcus 
in terms of being implicated in endocarditis, it has been reported that genitourinary infections 
predispose individuals to suffering from endocarditis due to this bacterium (Minces et al., 2010). As the 
literature shows, there is a need to recognize when this genus is the source of an infection in one of the 
various sites in the body. Furthermore, research shows that the differentiation in terms of the species is 
also clinically relevant in terms of the minimum inhibitory concentration (MIC} as will be discussed. 
Numerous sources suggest that the MICSO of P. anaerobius is higher than that of P. stomatis for 
several different antimicrobial agents. Before the two species were differentiated there were questions 
raised about the MIC values of microbes with Peptostreptococcus origins as, due to the lack of 
differentiation, it was unknown whether the penicillin used to treat the infection was the smallest 
effective dosage (Pathak et al., 2013). After the two species were found to be distinct, this led to a 
better understanding of why questions regarding MIC values formed and opened an opportunity for 
further research into determining these values for each P. anaerobius and P. stomatis. The following 
research delves into this question regarding MICSO values for the two species for several antimicrobial 
agents (Byrk et al., 2007). 
The data gathered in this research process fits well into the literature listed above as it furthers 
the knowledge compiled ih the source. The literature listed above first discusses the areas of extraction 
of these species, eventually proceeding into the similarities between P. anaerobius and P. stomatis at 
length. Since the research focuses on the differences between the two at a superficial level in regards to 
their species, the research performed differentiated them on a more specific level in regards to their 
genetic composition. The literature explains the difficulties of differentiating between these species so 
research designed to perform this task will supplement knowledge already compiled on the two species. 
In future application other researchers may even use this new primer design to differentiate P. 
anaerobius and P. stomatis rapidly to further their own experiments. As discussed prior, their research 
would be made more difficult if there was no rapid way to differentiate these two species. 
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Gram-positive anaerobic cocci-commensals and opportunistic pathogens 
Elizabeth Carmel Murphy & lnga-Maria Frick. Division of Infection Medicine, Department of Clinical 
Sciences, Lund University, Lund, Sweden. 2012 Federation of European Microbiological 
Societies. Published by John Wiley & Sons Ltd. 
Peptostreptococcus Induced Native-Valve Endocarditis 
R Pathak, A Ngwe, H Enuh, J Saverimuttu. Peptostreptococcus Induced Native-Valve Endocarditis. The 
Internet Journal of Infectious Diseases. 2013 Volume 12 Number 1 
' 
Peptostreptococcus infective endocarditis and bacteremia. Analysis of case-s at a tertiary medical 
center and review of the literature 
Minces LR, Shields RK, Sheridan K, Ho KS, Silveira FP. Anaerobe. 2010 Aug;16(4):327-30. doi: 
10.1016/j.anaerobe.2010.03.011. Epub 2010 Apr 3. 
Antimicrobial Susceptibilities of Peptostreptococcus anaerobius and the Newly Described 
Peptostreptococcus stomatis Isolated from Various Human Sources 
Antimicrobial Agents and Chemotherapy, June 2007, p. 2205-2207. Volume 51, Number 6. American 
Society for Microbiology. Eija Kononen, Anne Bryk, Paivi Niemi, and Arja Kanervo-Nordstrom 
Methods 
DNA Extraction Procedure: 
1. Grow bacterial culture at 32·c for 12h shaking (density- 106 CFU/ml). 
2. Pellet 1 ml of cells in a microcentrifuge at 10,000 rpm for 3 min. (RT). Discard supernatant into 
waste vessels at benches. 
3. Resuspend cells in 200ml sterile TE by repeated pipetting; Add 30ml10% SDS or 2.Sml 
proteinase K + Smllysozyme. Incubate 30-45 min. @ 37"C (water bath in CL28). Periodically 
during the incubation, vortex momentarily to enhance cell wall disruption. 
4. Boil 3-5 min. (or place tubes in a 9o·c water bath 5 min.); vortex 30sec. 
5. Spin tube(s) for 2 min. @ 2K rpm, RT, to pellet cellular debris. Decant or pipet supernatant into 
a clean, labeled tube. 
6. Add an equal volume of phenol (or chloroform) under hood; invert several times to mix very 
well. Centrifuge 10 min. @ 12K rpm (RT). 
7. Carefully pipet top phase into a new labeled tube and add 0.1 val. of cold 3M sodium acetate 
and 1 val. of cold ethanol (95%). Mix by inversion. 
8. Optional step: incubate tubes 0/N at -20"C 
9. Centrifuge @ max. speed in microcentrifuge for 20-30 min. (use microfuge in CL40 and/or CL34. 
Temp. can be either RT or 4·c. 
10. Decant liquid phase into waste vessel and dry DNA pellet for spectrophotometric determination. 
Components of PCR Trials: 
Negative Tube: 
25 mM MgCb 
2x buffer 
SYBR Green 
4 microliters 
12.5 microliters 
1 microliter 
Forward primer (exp.) 1 microliter 
Reverse primer (exp.) 1 microliter 
M-Mvlv enzyme mix 1 microliter 
Sterile Water 4.5 microliter 
Total 25 microliters 
Experimental Tube(s): 
25 mM MgCb 
2x buffer 
SYBR Green 
4 microliters 
12.5 microliters 
1 microliter 
Forward primer (exp.) 1 microliter 
Reverse primer (exp.) 1 microliter 
M-Mvlv enzyme mix 1 microliter 
Sterile Water (as needed) 
DNA sample (0.5 micrograms) 
Total 25 microliters 
Reference Tube: 
25 mM MgCh 
2x buffer 
SYBR Green 
4 microliters 
12.5 microliters 
1 microliter 
Forward primer (exp.) 1 microliter 
Reverse primer (exp.) 1 microliter 
M-Mvlv enzyme mix 1 microliter 
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Sterile Water 
DNA sample 
Total 
(as needed) 
(0.5 micrograms) 
25 microliters 
PCR primers used during the procedure appear as follows: 
ga/Kforward: 
ATCAGGAAACACCAACTCCG 
ga/K reverse: 
TACCGCACCCCACCGCTGGG 
fo/P forward: 
accccagattcattttcaga 
jo/P reverse: 
atggcatagccagaaagag 
ga/Tforward: 
tcaagtgacgggacatccga 
gaiT reverse: 
ttcgactagcatctatatcc 
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Results 
Trial1 (0 C} Trial 2 (°C) Trial 3 (°C) 
gaiT Reference (PA) 79.0 78.2 79.8 
Trial_1:1 
gaiT P. anaerobius 77.4 75.2 78.2 
.. 
Trial_1:2 
gaiT P. stomatis 78.8 78.5 76.1 
Trial 1:3 
fo/P Reference (PA) 78.8 (PS) 78.8 (PS) 74.5 
Trial 2:1 
fo/P P. anaerobius 75.8 74.2 74.5 
Trial_2:2 
foiP P. stomatis 80.8 78.1 79.2 
Trial 2:3 
ga/K Reference (PA) 75.8 80.8 77.5 
Trial_3:1 
gaiK P. anaerobius 76.8 79.1 81.1 
Trial_3:2 
ga/K P. stomatis 75.8 80.1 81.5 
Trial_3:3 
Table 1: Melting temperatures for each primer set in each trial performed. Reference sets used P. 
anaerobius and P. stomatis as available and are specified asP. anaerobius (PA) and P. stomatis (PS). 
Note: Info/PReference Trial_2:1, the parenthetical initials indicate the reference species for each of 
the three experimental trials. 
N Mean Std. Deviation 
Trial_1 1 3 78.03 1 .966 
-----
2 3 78.00 2.553 
----,.---·~ ··- ·- ·-~---··--.··--~ 
3 3 76.67 .808 
---- ···---------
Total 9 77.57 
--- ----·-~--------------
Trial_2 1 3 79.3667 
2 3 78.9000 
3 3 76.1667 
1.793 
·-------
1.25033 
1.05830 
2.58908 
g 78.1 444 Total 2.1 4191 
,.,.,.,.,.,_,_.,._,_.,..,,_,_~,-_,..,..,,,.._..,~---, _ . '"''"""'""""¥••••v••••v • ••v••••v• •••v••••v••v••••v••v~•••vv••v••••v••••v••••vvv••vv••v~··•v••• •vv••v••• •v••v ••••vv'"'"''"V"'""v••vyvvv• •vvv••vvvvvv••v•v• • 
Tfia1_:3J 1 2.65769 3 77.2667 
2 
3 
Tatar 
3 
3 
9 
78.9333 2.70986 
78.1667 3.6501 1 
78.1222 2.73028 
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Table 2: Statistical difference as calculated by SPSS 24 one way ANOVA analysis within groups 
(p < 0.05). Each trial is separated, and primers are denoted as follows: Reference (1), P. 
anaerobius (2), and P. stomatis (3). 
dFidT 
0.1 
005 
0 
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Figure 1: Raw melting temperature data from Trials 2 and 3 using the ga/K primer. Peaks found 
between 75-80 °C represent the point where the primers anneal to the specific gene sequence. 
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Figure 2: Raw melting temperature data from Trial 1 using the gaiT primer. Peaks found between 75-
80 oc represent the point where the primers anneal to the specific gene sequence. 
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Figure 3: Raw melting temperature data from Trial 3 using the fo/P primer. Peaks found between 75-
80 °C represent the point where the primers anneal to the specific gene sequence. 
Discussion 
The impact of differentiating the two bacteria P. anaerobius and P. stomatis lies in the fact each 
of these species of bacteria is implicated in various diseases for many different demographics. For 
example, according to one case study, P. anaerobius is implicated in sternal osteomyelitis, an infection 
that can stem from open wounds or surgical incisions (Y.-L. Chen et al, 2012). For example, P. anaerobius 
is implicated in bacterial vagi nos is in women as well as endocarditis for men and women age 65 and 
older. In addition, Peptostreptococcus stomatis is implicated in periodontal diseases, gingivitis, and root 
canal infections (Murphy and Frick, 2012). 
The MICso and MICgo to kill P. anaerobius is several orders of magnitude greater than those for P. 
stomatis for the antibiotics amoxicillin, clindamycin, and metronidazole (Kononen, 2007). This is of 
economic and medicinal importance, then, to differentiate between the two species to understand 
which ofthese species is implicated in the disease in question. Specifically, in regards to the economic 
impact, the price of drug spending (which included antibiotics) increased over 200 dollars per hospital 
admission from 2013 to 2015 (Pollack and Kahn, 2016). Being able to differentiate these bacteria with 
greater ease and efficiency will potentially allow for a reduced but equally effective dose of an 
antibiotic. 
In the clinical realm, the fewer outside substances exposed to the body is more desirable to 
prevent adverse side effects and this research is another key to making sure patients are treated with no 
more medication than is necessary to return them to their standard state of health (Weintraub, 
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2013}.This basic science research has the potential to be quickly applied to medical facilities such as 
emergency departments for its practical use in caring for patients. 
The results indicate that the gene sequences analyzed between the two species of 
Peptostreptococcus are not statistically different in terms of their melting temperatures. Such results are 
indicative that, in a limited view, these genes do not differentiate the species, and as such render our 
hypothesis invalid. In a broader scope this may lead to the conclusion that these species may not in fact 
be separate species but rather (whatever that word is to indicate they are different but not different 
enough to be distinct species}. However, the previous research discussed in relation to their MIC values 
would contradict such conclusion. A more appropriate interpretation of this outcome can be analyzed in 
terms of the genes selected. 
Concerning the genes selected, statistically the melting temperatures for the genes analyzed, 
jo/P, gaiT, and ga/K, were no different between Peptostreptococcus anaerobius and Peptostreptococcus 
stomatis. Such results present a difficult interpretation, as the literature indicated that these genes were 
physically not present within P. stomatis. Therefore, around the peaks of 75 to 80 degrees where these 
genes were recorded to occur in P. anaerobius, the melting temperatures for the analyzed sequence in 
P. stomatis should have been statistically different. Reasons to explain the disparity can include other 
gene sequences that would have the same melting temperatures as the genes being analyzed. 
Additionally, the primers may not have annealed to the correct gene sequences, thereby elongating 
genes that were not a part of the original hypothesis with similar melting temperatures. 
Further research into this area of study could involve looking at other genes that have been 
reported to be present in P. anaerobius and not P. stomatis. An example of this type of gene would be 
fum B. Such an extension on the research reported in this paper would be significant due to identifying 
other genes that are more readily distinguished between these two species of bacteria taking into 
account the similar characteristics of surrounding genes to the target genes. 
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